Cytori Therapeutics Says ATHENA Study Supports Symptomatic Benefit From Its Cell Therapy
May 06, 2016 at 10:08 AM EDT
Cytori Therapeutics Inc (NASDAQ: CYTX) revealed the presentation of six, as well as, the 12-month data from the ATHENA studies at the ...